SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS (216-119-132-66.ipset12.wt.net)
Subject: Re: vCJD cases likely haven't peaked
Date: February 2, 2005 at 1:02 pm PST

In Reply to: vCJD cases likely haven't peaked posted by TSS on February 2, 2005 at 12:55 pm:

-------- Original Message --------
Subject: Re: [CJDVoice] vCJD cases likely haven't peaked
Date: Wed, 02 Feb 2005 14:28:18 -0600
From: "Terry S. Singeltary Sr."
Reply-To: cjdvoice@yahoogroups.com
To: cjdvoice@yahoogroups.com
References: <420127B3.8000001@wt.net>


> i will do a search of an old thread from long ago on BSE-L
> where i got chastised for slamming someone about baby
> foods that said that special precautions had been taken.
> i never said i was politically correct ;-)


FOR those interested in this ongoing cover-up.
Sadly, I truly can say this with great confidence now.


From: TSS (216-119-129-14.ipset9.wt.net)
Subject: Re: IFST updated Information Statement on BSE and Variant
Creutzfeldt-Jakob Disease (vCJD)
Date: October 28, 2004 at 2:14 pm PST

In Reply to: IFST updated Information Statement on BSE and Variant
Creutzfeldt-Jakob Disease (vCJD)
posted by TSS
on October 28, 2004 at 8:27 am:

Greetings,

> BASE: Atypical cases of BSE in individual cattle have been found in
> Japan, France, Italy, the Netherlands, Belgium, Denmark and Poland.
> This appears to be a second cattle TSE which has been named bovine
> amyloidotic spongiform encephalopathy (BASE).


funny how this report fails to mention the most important aspect of this
study;

MOLECULAR SIMILARITIES WITH SPORADIC CJD !

nope, they cannot even bring themselves to say it $

THE new findings of BASE in cattle in Italy of Identification of a
second bovine amyloidotic spongiform encephalopathy: Molecular
similarities with sporadic Creutzfeldt-Jakob disease


http://www.pnas.org/cgi/content/abstract/0305777101v1

PLEASE ALLOW ME to correct the statement above with the following;

-------- Original Message --------
Subject: Re: IFST updated Information Statement on BSE and Variant
Creutzfeldt-Jakob Disease (vCJD)
Date: Thu, 28 Oct 2004 17:54:30 +0100
From: "J Ralph Blanchfield, MBE"
Reply-To: Bovine Spongiform Encephalopathy
Organization: Consultant
To: BSE-L@UNI-KARLSRUHE.DE
References: <4181113D.50407@wt.net>


##################### Bovine Spongiform Encephalopathy #####################

Dear Terry,

You are evidently so anxious to take the opportunity to expound your
conspiracy
theories that you rushed into print before bothering to go beyond the
seven page
Summary to the 68 page full text. If you had bothered to go to the full
text to
which you and others were directed, you would have found

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
BASE: atypical TSE in cattle

Casalone et al (2004) have provided evidence of a second cattle TSE. The
disorder, in a cow in Italy, was pathologically characterized by the
presence of
PrP-immunopositive amyloid plaques, as opposed to the lack of amyloid
deposition
in typical BSE cases, and by a different pattern of regional
distribution and
topology of brain PrPSc accumulation. In addition, Western blot analysis
showed
a PrPSc type with predominance of the low molecular mass glycoform and a
protease-resistant fragment of lower molecular mass than BSE-PrPSc.
Strikingly,
the molecular signature of this previously undescribed bovine PrPSc was
similar
to that encountered in a distinct subtype of sporadic CJD. This new form
with
amyloid plaques has been named bovine amyloidotic spongiform encephalopathy
(BASE). Similar cases have been described in France [Biacabe et al (2003)],
Belgium, Denmark, The Netherlands and Japan,

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

You added the $ insult when you know full well that IFST is not
influenced by $$
or ££.

Don't you think an apology is due from you, and a promise of more care
in the
future?

Best wishes
Ralph
******************************************************
Prof J Ralph Blanchfield, MBE
Food Science, Food Technology and Food Law Consultant
Chair, External Affairs, Institute of Food Science and Technology
Webmaster / Web Editor, Institute of Food Science and Technology
Vice President, European Food Law Association of the UK
Adjunct Professor, Michigan State University
IFST Web address
Personal Web address
***************************************************************

-------- Original Message --------
Subject: Re: IFST updated Information Statement on BSE and Variant
Date: Thu, 28 Oct 2004 12:33:52 -0500
From: "Terry S. Singeltary Sr."
Reply-To: Bovine Spongiform Encephalopathy
To: BSE-L@UNI-KARLSRUHE.DE
References: <4181113D.50407@wt.net>


##################### Bovine Spongiform Encephalopathy #####################

hello there Ralph,

many thanks for your kind reply ;-)

but why bury it in 68 pages when it should have been put in the short
summary most people would read?

>Don't you think an apology is due from you, and a promise of more care
in the
>future?
>

nope.............

kind regards,
terry

-------- Original Message --------
Subject: Re: IFST updated Information Statement on BSE and Variant
Date: Thu, 28 Oct 2004 18:52:30 +0100
From: "J Ralph Blanchfield, MBE"
Reply-To: Bovine Spongiform Encephalopathy
Organization: Consultant
To: BSE-L@UNI-KARLSRUHE.DE
References: <4181113D.50407@wt.net> <41812D80.6050603@wt.net>


##################### Bovine Spongiform Encephalopathy #####################

Hello Terry,

Anyone seriously interested in the subject (instead of merely wanting to
grind
an axe) would read the full text. I am really surprised that you did not
bother
to do so or, having seen the item in the Summary, did not even do a
(Control+F)
search for "BASE" or "Castelone" in the full text. In these days of
ability to
search electronic documents, nothing is "buried", as you well know.

For someone who provides a lot of valuable information on BSE-L as you
do, it
is very sad that you also behave so boorishly. The hardest word to say is
"Sorry". Evidently it is beyond you. I really pity you.

Best wishes
Ralph
******************************************************
Prof J Ralph Blanchfield, MBE
Food Science, Food Technology and Food Law Consultant
Chair, External Affairs, Institute of Food Science and Technology
Webmaster / Web Editor, Institute of Food Science and Technology
IFST Web address
Personal Web address
***************************************************************
Note: All outgoing e-mails have been scanned for all
known viruses by the latest version of Norton Anti-virus.

-------- Original Message --------
Subject: Re: IFST updated Information Statement on BSE and Variant
Date: Thu, 28 Oct 2004 15:03:39 -0500
From: "Terry S. Singeltary Sr."
Reply-To: Bovine Spongiform Encephalopathy
To: BSE-L@UNI-KARLSRUHE.DE
References: <4181113D.50407@wt.net> <41812D80.6050603@wt.net>


##################### Bovine Spongiform Encephalopathy #####################

Hello again Ralph,

>For someone who provides a lot of valuable information on BSE-L as you
do, it
>is very sad that you also behave so boorishly. The hardest word to say is
>"Sorry". Evidently it is beyond you. I really pity you.
>
>

oh Ralph, don't pity me, you should pity the fools that got us
in this mess, some that seem to want to make the same mistakes
over and over again.

also, your mind seems to slip you there friend,
i am the first to say i am sorry or admit things if i am
wrong, and have said it before to you ;

Date: Sat, 27 Nov 1999 12:03:22 +0000
Reply-To: BSE-L
Sender: BSE-L
From: J Ralph Blanchfield
Organization: Consultant
Subject: Re: Girl, 13, shows CJD symptoms. [re-baby food]
In-Reply-To:

BSE-L

Hello Terry and Everyone,

On Fri, 26 Nov 1999 10:36:34 -0600, Terry wrote:

>Hello Ralph and All, >I think you are correct Ralph, after reading
back over my comments, I was a bit >hasty, and in a friends eyes, may
have even seemed rude. >For that I would like to apologize to Heather
and You.

Thank you. I shall forward your post on to Heather, and invite her to
send me a response, which I shall forward to BSE-L.

>It still does not change my position on the matter. It would have been
better >directed, if I would have directed my haste, to the _whole_
industry involved, as >opposed to Heather and the Baby Food industry.
>For obvious reasons, if the DFA's are accurate, and the statements
within from the >Working Party and the Gov. and the statement from the
manufacturers of Baby Foods, >where they are stating in DFA 9; >"152.
There is no evidence of written assurances from the manufacturers
supplied >to either Maff or the Department of Health asserting that Baby
Food did not >contain bovine brain, spinal cord, spleen, intestines or
thymus".


snip...end

hello again Ralph,


>Anyone seriously interested in the subject (instead of merely wanting
to grind
>an axe) would read the full text.
>

dont' worry there, i had intended on it, just have not had time yet,
i was more interested in the TSE infection in a goats brain which tests
cannot distinguish from BSE, this was big news to me and was still
reading that.

Ralph, it seems i have hit your sore spot again and did not intend to do
so. but i am very disturbed that every time a report comes out from
Gov. officials and or food safety experts, studies that support sporadic
CJD as not being so sporadic/spontaneous as some in the industry would
like, studies that show 'Molecular similarities with sporadic
Creutzfeldt-Jakob disease ', i mean, how much space would that have
taken up in the summary?

you have a second TSE in cattle, BUT THIS TIME it has molecular
similarities with sporadic CJD, and it is being documented in a growing
number of countries? why is not the media reading this and reporting it?
could it because it was not in the summary and they did not read the
full report?
i hope not...

something _this_ important should have read ;

''BASE: Atypical cases of BSE in individual cattle have been found in
Japan, France, Italy, the Netherlands, Belgium, Denmark and Poland. This
appears to be a second cattle TSE which has been named bovine
amyloidotic spongiform encephalopathy (BASE), with Molecular
similarities with sporadic Creutzfeldt-Jakob disease.''

i mean, this is how the title reads ;


Medical Sciences
Identification of a second bovine amyloidotic spongiform
encephalopathy: Molecular similarities with sporadic
Creutzfeldt-Jakob disease


NOW, that is how it should have read, unless the PUBLIC FEAR FACTOR
CONTROL switched was turned on again, to omit the most important aspect
of this research in the summary. just my opinion, and i hate to play the
race
card, but you called it, so YES, i have a grind to ax, hvCJD Mom dod
12/14/97.
BUT i grind my ax with facts, all of them.

MY point was not to turn on Ralphs mad button:-)

FACTS are facts and fact is, the 85%+ of all CJD 'sporadic' needs to be
at the forefront of this research, not on the back burners. call it a rant,
call it a grind to ax, call it whatever you want, but here are the
facts that are being ignored, and this was my point ;

IN light of Asante/Collinge et al findings that BSE transmission to the
129-methionine genotype can lead to an alternate phenotype that is
indistinguishable from type 2 PrPSc, the commonest _sporadic_ CJD;

-------- Original Message -------- Subject: re-BSE prions propagate as

either variant CJD-like or sporadic CJD Date: Thu, 28 Nov 2002 10:23:43

-0000 From: "Asante, Emmanuel A" To:
"'flounder@wt.net'"

Dear Terry,

I have been asked by Professor Collinge to respond to your request. I am

a Senior Scientist in the MRC Prion Unit and the lead author on the

paper. I have attached a pdf copy of the paper for your attention. Thank

you for your interest in the paper.

In respect of your first question, the simple answer is, yes. As you

will find in the paper, we have managed to associate the alternate

phenotype to type 2 PrPSc, the commonest sporadic CJD.

It is too early to be able to claim any further sub-classification in

respect of Heidenhain variant CJD or Vicky Rimmer's version. It will

take further studies, which are on-going, to establish if there are

sub-types to our initial finding which we are now reporting. The main

point of the paper is that, as well as leading to the expected new

variant CJD phenotype, BSE transmission to the 129-methionine genotype

can lead to an alternate phenotype which is indistinguishable from type

2 PrPSc.

I hope reading the paper will enlighten you more on the subject. If I

can be of any further assistance please to not hesitate to ask. Best
wishes.

Emmanuel Asante

<> ____________________________________

Dr. Emmanuel A Asante MRC Prion Unit & Neurogenetics Dept. Imperial

College School of Medicine (St. Mary's) Norfolk Place, LONDON W2 1PG

Tel: +44 (0)20 7594 3794 Fax: +44 (0)20 7706 3272 email:

e.asante@ic.ac.uk (until 9/12/02)

New e-mail: e.asante@prion.ucl.ac.uk (active from now)

____________________________________

snip...

full text ;

http://www.fda.gov/ohrms/dockets/ac/03/slides/3923s1_OPH.htm

BSE prions propagate as either variant CJD-like or sporadic CJD-like
prion strains in transgenic mice expressing human prion protein

Emmanuel A. Asante, Jacqueline M. Linehan, Melanie Desbruslais, Susan
Joiner, Ian Gowland, Andrew L. Wood, Julie Welch, Andrew F. Hill, Sarah
E. Lloyd, Jonathan D.F. Wadsworth and John Collinge1

MRC Prion Unit and Department of Neurodegenerative Disease, Institute of
Neurology, University College, Queen Square, London WC1N 3BG, UK 1
Corresponding author e-mail: j.collinge@prion.ucl.ac.uk


Received August 1, 2002; revised September 24, 2002; accepted October
17, 2002

Abstract


Variant CreutzfeldtJakob disease (vCJD) has been recognized to date
only in individuals homozygous for methionine at PRNP codon 129. Here we
show that transgenic mice expressing human PrP methionine 129,
inoculated with either bovine spongiform encephalopathy (BSE) or variant
CJD prions, may develop the neuropathological and molecular phenotype of
vCJD, consistent with these diseases being caused by the same prion
strain. Surprisingly, however, BSE transmission to these transgenic
mice, in addition to producing a vCJD-like phenotype, can also result in
a distinct molecular phenotype that is indistinguishable from that of
sporadic CJD with PrPSc type 2. These data suggest that more than one
BSE-derived prion strain might infect humans; it is therefore possible
that some patients with a phenotype consistent with sporadic CJD may
have a disease arising from BSE exposure...

http://embojournal.npgjournals.com/cgi/content/full/21/23/6358

THE new findings of BASE in cattle in Italy of Identification of a
second bovine amyloidotic spongiform encephalopathy: Molecular
similarities with sporadic Creutzfeldt-Jakob disease


http://www.pnas.org/cgi/content/abstract/0305777101v1


Adaptation of the bovine spongiform encephalopathy agent to primates
and comparison with Creutzfeldt- Jakob disease: Implications for
human health

THE findings from Corinne Ida Lasmézas*, [dagger] , Jean-Guy Fournier*,
Virginie Nouvel*,

Hermann Boe*, Domíníque Marcé*, François Lamoury*, Nicolas Kopp [Dagger

] , Jean-Jacques Hauw§, James Ironside¶, Moira Bruce [||] , Dominique

Dormont*, and Jean-Philippe Deslys* et al, that The agent responsible
for French iatrogenic growth hormone-linked CJD taken as a control is
very different from vCJD but is similar to that found in one case of
sporadic CJD and one sheep scrapie isolate;

http://www.pnas.org/cgi/content/full/041490898v1

Characterization of two distinct prion strains
derived from bovine spongiform encephalopathy
transmissions to inbred mice

Sarah E. Lloyd, Jacqueline M. Linehan, Melanie Desbruslais,
Susan Joiner, Jennifer Buckell, Sebastian Brandner,
Jonathan D. F. Wadsworth and John Collinge

Correspondence
John Collinge
j.collinge@prion.ucl.ac.uk

MRC Prion Unit and Department of Neurodegenerative Disease, Institute of
Neurology,
University College, London WC1N 3BG, UK
Received 9 December 2003
Accepted 27 April 2004

Distinct prion strains can be distinguished by differences in incubation
period, neuropathology
and biochemical properties of disease-associated prion protein (PrPSc)
in inoculated mice.
Reliable comparisons of mouse prion strain properties can only be
achieved after passage in
genetically identical mice, as host prion protein sequence and genetic
background are known
to modulate prion disease phenotypes. While multiple prion strains have
been identified in
sheep scrapie and CreutzfeldtJakob disease, bovine spongiform
encephalopathy (BSE) is
thought to be caused by a single prion strain. Primary passage of BSE
prions to different lines
of inbred mice resulted in the propagation of two distinct PrPSc types,
suggesting that two
prion strains may have been isolated. To investigate this further, these
isolates were
subpassaged in a single line of inbred mice (SJL) and it was confirmed
that two distinct prion
strains had been identified. MRC1 was characterized by a short
incubation time (110±3 days),
a mono-glycosylated-dominant PrPSc type and a generalized diffuse
pattern of PrP-immunoreactive
deposits, while MRC2 displayed a much longer incubation time (155±1 days),
a di-glycosylated-dominant PrPSc type and a distinct pattern of
PrP-immunoreactive deposits
and neuronal loss. These data indicate a crucial involvement of the host
genome in modulating
prion strain selection and propagation in mice. It is possible that
multiple disease phenotypes
may also be possible in BSE prion infection in humans and other animals.

http://vir.sgmjournals.org/cgi/content/abstract/85/8/2471

1: J Infect Dis 1980 Aug;142(2):205-8


Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to
nonhuman primates.

Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC.

Kuru and Creutzfeldt-Jakob disease of humans and scrapie disease of
sheep and goats were transmitted to squirrel monkeys (Saimiri
sciureus) that were exposed to the infectious agents only by their
nonforced consumption of known infectious tissues. The asymptomatic
incubation period in the one monkey exposed to the virus of kuru was
36 months; that in the two monkeys exposed to the virus of
Creutzfeldt-Jakob disease was 23 and 27 months, respectively; and
that in the two monkeys exposed to the virus of scrapie was 25 and
32 months, respectively. Careful physical examination of the buccal
cavities of all of the monkeys failed to reveal signs or oral
lesions. One additional monkey similarly exposed to kuru has
remained asymptomatic during the 39 months that it has been under
observation.

PMID: 6997404

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6997404&dopt=Abstract

ALL animals for human/animal consumption must be tested for TSE.

ALL human TSEs must be made reportable Nationally and Internationally...tss

P.S.

Ralph, sorry i hurt your feelings, but i am not sorry for trying to tell
the whole truth.

this i will continue to do.

have a nice day...

kind regards,
terry

http://www.vegsource.com/talk/madcow/messages/93431.html

Re: IFST updated Information Statement on BSE and Variant
Creutzfeldt-Jakob Disease (vCJD)
TSS 10/29/04 (1)

-------- Original Message --------
Subject: Re: IFST updated Information Statement on BSE and Variant
Date: Fri, 29 Oct 2004 10:09:52 -0500
From: "Terry S. Singeltary Sr."
To: Bovine Spongiform Encephalopathy
References: <2d5be8d2d5b51f.2d5b51f2d5be8d@ryerson.ca>


Greetings list members,

i will try to address all comments on this here in this one email.


>Ralph Blanchfield is a highly respected food scientist
>on both sides of the Atlantic. And at an age when most of
>us would be relegated to carpet slippers and a good book,
>he retains one of the sharpest and most analytical minds
>you can find, and has been a constant source of both accurate
>and critical information throughout the entire BSE/vCJD/CWD saga.
>
>As June says- let's keep on track!
>


hello tim and june,

thanks, point _well_ taken.

and thanks to brian for explaining better what i tried to explain yesterday;

>Group,
>
>In my experience of writing papers - not in the food science area but
in another technical field - it is usual to prepare a concise but
accurate summary of the topic. To take 10% of the length of the original
text as a summary is exceptionally long. To take this space and to omit
key information is also exceptional. Perhaps the authors of the paper
should be encouraged to re-examine their summary with these points in mind?
>


i think everyone missed my point;


> i mean, this is how the title reads ;
>
>
> Medical Sciences
> Identification of a second bovine amyloidotic spongiform
> encephalopathy: Molecular similarities with sporadic
> Creutzfeldt-Jakob disease


to leave out the most important part in the 9 page summary,
TO CUT THE TITLE OF THE RESEARCH PAPER IN HALF
as to omit the most important part, just to bury it in 68 page full text,
i still think is wrong, IF you are trying to be up front with the public.
whether or not i read the full 68 pages yesterday was not my point,
my point was in the 9 page summary, which i did read and that most
would read. just my opinion and evidently my opinion is not welcomed here,
so i will not comment on the full text version, of which i have now read...

as for the great wizard of oz comment ;

>I didn't see terry's postings as I killfiled him long ago.
>The only person in this group I have ever done that for.
>

not worth commenting on...

at any rate, as far as i am concerned, this thread is dead.

kind regards,
terry


Tim Sly wrote:

>##################### Bovine Spongiform Encephalopathy
#####################
>
>Thanks June. I want to endorse what you've said.
>
> Terry, I/we continue to appreciate your
>tenacity and dilligence in bringing to light relevant
>documents. You are doing a great job.
>
>But please don't obscure this valuable work with the
>relentless expounding of personal agendae, conspiracy
>theories, and (worst of all) spontaneous misinformed
>outbursts against people who are in fact very well informed.
>
>Ralph Blanchfield is a highly respected food scientist
>on both sides of the Atlantic. And at an age when most of
>us would be relegated to carpet slippers and a good book,
>he retains one of the sharpest and most analytical minds
>you can find, and has been a constant source of both accurate
>and critical information throughout the entire BSE/vCJD/CWD saga.
>
>As June says- let's keep on track!
>
>Best regards to you and Ralph
>
>
>Tim Sly MSc PhD DPHI CPHI(C)
>School of Occupational & Public Health
>Ryerson University. Toronto, Canada
>
>################# BSE-L-subscribe-request@uni-karlsruhe.de
#################

http://www.vegsource.com/talk/madcow/messages/93432.html


Re: IFST updated Information Statement on BSE and Variant
Creutzfeldt-Jakob Disease (vCJD)
TSS 11/02/04 (0)

-------- Original Message --------
Subject: Re: IFST updated Information Statement on BSE and Variant CJD
Date: Tue, 2 Nov 2004 23:05:03 +0000
From: "J Ralph Blanchfield, MBE"
Reply-To: Bovine Spongiform Encephalopathy
Organization: Consultant
To: BSE-L@UNI-KARLSRUHE.DE
References: <4181113D.50407@wt.net> <41812D80.6050603@wt.net>
<008201c4bd90$dddff9c0$8db8f13e@oemcomputer>


##################### Bovine Spongiform Encephalopathy #####################

Hello Brian and Everyone,

As regards the "exceptional" length of the Summary, BSE/vCJD, as all on
BSE-L know, is an exceptional multi-faceted subject. The Summary, which as a
Word file actually prints out to a little over 5 x A4 pages of 11 point
Arial,
has to cover 28 separate topics within the subject. Having regard to
that, it is
far from "exceptional" in length.

On the question of the BASE item in the Summary, the phrase at issue was not
intentionally omitted from the Summary -- but of course there are many
important
pieces of detailed information in the 68 pages of the full text that
would not
fit in to the 5+ pages of Summary.

As you have appreciated, Brian, I cannot modify the Summary "off my own
bat" but
I have consulted the two IFST Committees concerned (the Technical &
Legislative
Committee and the Public Affairs Committee) via their listservs. Both
have now
approved my suggestion of the addition, at the end of the BASE item in the
Summary, of the phrase "and has molecular similarity to a sub-type of
sporadic
CJD".

BTW, as far as my personal position is concerned, I have on my personal
Website
www.jralphb.co.uk a Powerpoint presentation on BSE/vCJD, which has been
there
for two years,originally given as a presentation in a symposium in USA
in 2002,
and in updated form on a few occasions since then, but updated monthly
(now with
too much information on as few of the slides!). The mention of "molecular
similarity to sporadic CJD" in question appeared in the slide (#43)
about the
Casalone et al paper that has been there since the paper was first
published,
and indeed a similar phrase in the slide (#79) of the Asante et al paper
that
has been there since the Powerpoint presentation was first assembled.

Anyway, the IFST updated Information Statement on BSE and Variant CJD
may be accessed at www.ifst.org/hottop5.htm

Best wishes
Ralph
******************************************************
Prof J Ralph Blanchfield, MBE
Food Science, Food Technology and Food Law Consultant
Chair, External Affairs, Institute of Food Science and Technology
Webmaster / Web Editor, Institute of Food Science and Technology
IFST Web address
Personal Web address
***************************************************************
Note: All outgoing e-mails have been scanned for all
known viruses by the latest version of Norton Anti-virus.
***************************************************************

On Fri, 29 Oct 2004 09:25:31 +0100, you wrote:

>##################### Bovine Spongiform Encephalopathy
#####################

http://www.vegsource.com/talk/madcow/messages/93454.html

Approved-By: "Terry S. Singeltary Sr." Message-ID: <383D702F.1258768B@wt.net> Date: Thu, 25 Nov 1999 11:21:52 -0600 Reply-To: Bovine Spongiform
Encephalopathy Sender: Bovine Spongiform Encephalopathy From: "Terry S. Singeltary Sr."

Subject: Re: Girl, 13, shows CJD symptoms. [re-baby food]


######### Bovine Spongiform Encephalopathy
######### Hello Robert and All, I would like to point out in DFA 9
99. Mr. Lawrence wrote a letter
to Sir Richard on 6 January 1989 (110) explaining that there were _no_
special regulations with regard to the composition of baby food except
in relation to additives, and that there was therefore _nothing_ in the
rules that would exclude certain parts of animal being incorporated into
baby foods as long as they were fit for human consumption. 152. There is
_no_ evidence of written assurances from the manufacturers supplied to
either MAFF or the Department of Health asserting that Baby Food did not
contain bovine brain, spinal cord, spleen, intestines or thymus. 155.
The reply also outlined the following actions already taken or to be
taken by the Government in response to the Working Party's
recommendations. 1) As a precautionary measure the Government would
enact secondary legislation to ensure it was illegal to sell Baby Food
containing brain, spinal cord, spleen and intestines. 165. On 23 May
1989 Mr. Cockbill prepared draft regulations prohibiting the use of
certain _specified offals_ in Baby Foods... Kind Regards, Terry S.
Singeltary Sr., Bacliff, Texas USA "Robert A. LaBudde" wrote: >
######### Bovine Spongiform Encephalopathy
######### > > At 11:35 AM 11/24/99 -0600, Terry wrote: > >Heather Paine
should be educated on the products she over-sees. These > >children's >
>health are at risk, and if she does not know what has and has not been
> >going into > >baby-foods, she does not need to hold that position.
The Inquiry was very > >concerned > >about baby foods, and at one point
said something about; > > It is very unlikely that baby food would
contain SBO's, since baby food is > the most highly regulated and safest
of all commercial foods. > > So, if baby food is suspected as a vehicle
for BSE->ukCJD, then it would be > base on its containing normal cuts of
meat. Baby foods contain more liver > than the general population eats,
so perhaps there could be a correlation > there. > > Babies of all
species have more porous intestinal membranes, so uptake of > prions
would be expected to be more efficient. > >
================================================================ >
Robert A. LaBudde, PhD, PAS, Dpl. ACAFS e-mail: ral@lcfltd.com > Least
Cost Formulations, Ltd. URL: http://lcfltd.com/ > 824 Timberlake Drive
Tel: 757-467-0954 > Virginia Beach, VA 23464-3239 Fax: 757-467-2947 > >
"Vere scire est per causae scire" >
================================================================ > >
############ http://mailhost.rz.uni-karlsruhe.de/warc/bse-l.html
############

Approved-By: J Ralph Blanchfield
Message-ID:
Date: Thu, 25 Nov 1999 22:30:36 +0000
Reply-To: Bovine Spongiform Encephalopathy
Sender: Bovine Spongiform Encephalopathy
From: J Ralph Blanchfield
Organization: Consultant
Subject: Re: Girl, 13, shows CJD symptoms. [re-baby food]
In-Reply-To: <4.2.2.19991125131318.03a98c40@mailhub.exis.net>

######### Bovine Spongiform Encephalopathy
######### Hello Robert, Terry and Everyone, On Thu, 25 Nov 1999 13:17:45
-0500, Robert LaBudde wrote: >######### Bovine Spongiform Encephalopathy
######### > >At 11:21 AM 11/25/99 -0600, Terry
wrote: >>I would like to point out in DFA 9
>> >>99. Mr. Lawrence wrote a
letter to Sir Richard on 6 January 1989 (110) >>explaining >>that there
were _no_ special regulations with regard to the composition of >>baby
>>food except in relation to additives, and that there was therefore
>>_nothing_ in >>the rules that would exclude certain parts of animal
being incorporated >>into baby >>foods as long as they were fit for
human consumption. >> >>152. There is _no_ evidence of written
assurances from the manufacturers >>supplied >>to either MAFF or the
Department of Health asserting that Baby Food did >>not contain >>bovine
brain, spinal cord, spleen, intestines or thymus. >> >>155. The reply
also outlined the following actions already taken or to be >>taken by
>>the Government in response to the Working Party's recommendations.
>>1) As a precautionary measure the Government would enact secondary
>>legislation to >>ensure it was illegal to sell Baby Food containing
brain, spinal cord, >>spleen and >>intestines. >> >>165. On 23 May 1989
Mr. Cockbill prepared draft regulations prohibiting >>the use of
>>certain _specified offals_ in Baby Foods... > >Thanks for the
relevant information, Terry. > >I over-generalized based on US
experience. There's a thick wad of FDA >regulations concerning baby food
in this country, and I made the mistake of >presuming that this was a
similar occurrence in Europe. > >If the UK was really this cavalier
about baby food, the regulations on >'normal' food must be very weak.
It's still hard to believe this is really >true. > >Perhaps JRalph could
help us out with an authoritative comment on this issue. I'll do my
best. You really are keeping me hard at work today here and elsewhere,
aren't you, Robert? _Specific_ Regulations relating to baby foods
prohibit added colours, artificial sweeteners and some additives, limit
pesticide residues and vitamin A content. There are no "recipe"
Regulations affecting them. Baby foods, and all other foods, are subject
to the general provisions that are in the Food Safety Act 1990 and were
in its predecessors all the way back to 1872.. Section 7 of the 1990 Act
states: 7. Rendering food injurious to health
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ (1) Any person who renders any food
injurious to health by means of any of the following operations, namely-
(a) adding any article or substance to the food; (b) using any article
or substance as an ingredient in the preparation of the food; (c)
abstracting any constituent from the food; and (d) subjecting the food
to any other process or treatment; with intent that it shall be sold for
human consumption, shall be guilty of an offence. (2) In determining for
the purposes of this section and section 8(2) below whether any food is
injurious to health, regard shall be had- (a) not only to the probable
effect of that food on the health of a person consuming it; but (b) also
to the probable cumulative effect of food of substantially the same
composition on the health of a person consuming it in ordinary
quantities. (3) In this Part injury, in relation to health, includes
any impairment, whether permanent or temporary, and injurious to
health shall be construed accordingly. Section 8 contains two
provisions -- 8(2)(b) and 8(2)(c) -- not in the predecessors of the 1990
Act: 8 Selling food not complying with food safety requirements
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ (1) Any person who- (a)
sells for human consumption, or offers, exposes or advertises for sale
for such consumption, or has in his possession for the purpose of such
sale or of preparation for such sale; or (b) deposits with, or consigns
to, any other person for the purpose of such sale or of preparation for
such sale, any food which fails to comply with food safety requirements
shall be guilty of an offence. (2) For the purposes of this Part food
fails to comply with food safety requirements if- (a) it has been
rendered injurious to health by means of any of the operations mentioned
in section 7(1) above; (b) it is unfit for human consumption; or (c) it
is so contaminated (whether by extraneous matter or otherwise) that it
would not be reasonable to expect it to be used for human consumption in
that state, and references to such requirements or to food complying
with such requirements shall be construed accordingly. (3) Where any
food which fails to comply with food safety requirements is part of a
batch, lot or consignment of food of the same class or description, it
shall be presumed for the purposes of this section and section 9 below,
until the contrary is proved, that all of the food in that batch, lot or
consignment fails to comply with those requirements. (4) For the
purposes of this Part, any part of, or product derived wholly or partly
from, an animal- (a) which has been slaughtered in a knackers yard, or
of which the carcase has been brought into a knackers yard; or (b) in
Scotland, which has been slaughtered otherwise than in a slaughterhouse,
shall be deemed to be unfit for human consumption. (5) In subsection (4)
above, in its application to Scotland, animal means any description of
cattle, sheep, goat, swine, horse, ass or mule; and paragraph (b) of
that subsection shall not apply where accident, illness or emergency
affecting the animal in question required it to be slaughtered as
mentioned in that paragraph. Baby foods, like all foods, are of course
also subject to the extensive provisions of the Food Safety (General
Food Hygiene) Regulations 1995 (and parallel Hygiene Regulations
covering specific food sectors). It is easy with the 20/20 vision of
hindsight to say now that certain animal derivatives should not have
been used in baby foods (and indeed we do not know that they were, and
Heather Paine is quoted as saying that to her knowledge they were not).
Until the investigations of the Southwood Committee, there was anyway no
reason to suppose that these materials, from apparently healthy cows,
were other than wholesome or had any connection with BSE or indeed vCJD
(the existence of which was at that point unknown). As it happens, the
food manufacturer for which I worked in the early 1950s, among its many
canned, bottled, frozen and dehydrated products, manufactured a range of
baby foods including a beef broth, which was made from Argentinian
frozen beef -- no offals of any kind. But each manufacturer decided for
itself what ingredients to use, and they were/are in no way controlled
or "overseen" by a trade association, which is what the Infant and
Dietetic Foods Association was/is. So Terry, your attack on Heather
Paine was unwarranted and badly misconceived, and I think you owe her an
apology. I happen to know Heather well in an entirely different
connection, and a more honest and conscientious person it would be hard
to find. Finally, if it is vCJD, there is no more reason to suppose that
the girl in question acquired the infection from baby food than from
infected mince after weaning or from the infected vaccines that we now
know were in use. Regards Ralph
****************************************************************** J
Ralph Blanchfield MBE Food Science, Food Technology & Food Law
Consultant Chair, IFST External Affairs Web Editor, Institute of Food
Science & Technology IFST Web address e-mail:
ICQ# 6254687. ICQ Web page

******************************************************************
############ http://mailhost.rz.uni-karlsruhe.de/warc/bse-l.html
############


>Finally, if it is vCJD, there is no more reason to suppose that the girl in
>question acquired the infection from baby food than from infected mince
>after weaning or from the infected vaccines that we now know were in use.
>
>Regards
>Ralph
>******************************************************************
>J Ralph Blanchfield MBE
>Food Science, Food Technology & Food Law Consultant
>Chair, IFST External Affairs
>

AND that's a complete different can of worms ;

THESE documents acquired via FOIA before online via BSE-L ;


Two million children innoculated with BSE vaccines


http://www.mad-cow.org/00/may00_news.html#aaa

From: TSS (216-119-138-163.ipset18.wt.net)
Subject: RE--CJD&CHILDREN-- could the 'v' in vCJD simply mean vaccineCJD?
Date: September 10, 2000 at 8:47 am PST

######### Bovine Spongiform Encephalopathy #########

Greetings List members,

thought i would pass this about vaccineCJD. But i would be curious
to know, how many times has this happened? How many documented
cases of this type transmission of a TSE with animals? The
scrapie agent has been the one used most, to study CJD. Why
could it not be, that the "V" in vCJD, mean vaccineCJD?
It could explain the children and CJD. With the deaths of these
young people, has anyone looked at their vaccination records?
just a thought???

kind regards,
Terry S. Singeltary SR., Bacliff, Texas USA

There has been one instance of inadvertant [sic] transmission of the
scrapie agent to sheep through louping ill vaccine (Gordon, Bronlee and
Wilson 1939). One of the three batches of vaccine made in 1935 at the
Moredun Institute contained the scrapie agent resulting in 7% of the
recipients of the 18, 000 doses in the batch developing scrapie. This
vaccine was made from formalin-inactivated sheep brain, and brought to
the attention of research workers that formalin, at a concentration of
0.35% for at least 3 months, which inactivated conventional viruses, did
not totally inactivate the scrapie agent.
----------------------------
4. Questions we might want to have answered are:
the highest risk would be from parenterals prepared from brain (eg
rabies vaccine). Any species in which transmissible spongiform
encephalopathies have been described would be suspect (natural
infections in sheep, goats, cattle, deer, mink, but can be transmitted
to hamster, mouse, guinea-pig etc). Are sterilisation processes
adequate for the most resistant strain of scrapie agent or for CJD
agent? Should companies be asked to include investigation for inclusion
of scrapie agent (eg mouse innoculation [sic]) in at least some batches?
If BSE behaves like scrapie, then we might expect other nervous tissue,
spleen, lymph nodes and placenta to be contaminated. Infection has been
described in other tissues too, eg gut wall, and we can not [sic] be
sure blood is free. Do we know what bovine materials are used in which
products, both as the active ingredient and in production? Bovine active
ingredients in human products include insulin, vasopressin, bone, immune
globulins, fibrin, dermal collagen, albumin. Bovine serum albumin and
fetal calf serum must be used in preparation of very many products. For
each of these products would any BSE agent be destroyed or eliminated
in processing? If not, and the product is administered parenterally or
topically into an open wound, might there be a risk? [For oral
products, there would only be a trivially increased load on top of that
taken in food in omnivores/carnivores including man. But for some
herbivores, this might allow the agent to be introduced into yet another
species].
--------------------------
Medicines and medical devises;

and they are still asking the same damn questions, over and over
again. This was 2 June 1988. we must act soon, or forget it, the hope
of eradicating human TSE's will be out the door.

kind regards,
Terry S. Singeltary Sr., Bacliff, Texas USA

"Terry S. Singeltary Sr." wrote:
>
> ######### Bovine Spongiform Encephalopathy #########
>
> Greetings list members,
>
> this document is very disturbing, considering if they continued to use
> these vaccines, the U.K. could loose a generation of children. If they
> continue to force these vaccines on children, they could loose more than
> just one generation, looking at the inventory. I did not know, that a
> Government body or bodies, if you include the United States, could be
> so stupid to this disease, with the evidence they have to date.
> It's as blatant and negligent as you can get. You may think the BSE
> Inquiry is almost over, but that was only the beginning.
>
> The Truth Will Come...
> (just hope i'm alive to see it)
>
> kind regards,
> Terry S. Singeltary Sr., Bacliff, Texas USA
> ============================================
>
> BSE3/1 0250
>
> Dr Harris (MED)
>
> From: Dr Adams (MB3B)
>
> cc - Dr. Pickles
>
> Date: 14 February 1989
>
> BOVINE SPONGIFORM ENCEPHALOPATHY
>
> This minute details the information received on human vaccines in
> response to telephone enquires, and details of forthcoming expert
> group meetings during February 1989.
>
> Vaccines
>
> We have contacted all the major vaccine product licence holders whose
> products are likely to be used in children. Many manufacturers use
> bovine material. As can be seen, this information is diverse and
> incomplete. Each company stressed that they could not give an accurate
> assessment without detailed researches, given the complexity of
> sourcing/purchasing arrangements.
>
> All the licences are detailed in appendix 1; the overview is as follows;
>
> 1. XXXXXXXXXXX have polio, measles, mumps, rubella, rotavirus vaccines.
> AlL use bovine serum from a UK source and bovine commercial product from
> unknown source. Some agent comes from the USA and New Zealand.
>
> 2. XXXXXXXXXXX (see Appendix 2). All their vaccines apart from yellow
> fever, cholera and typhoid contain bovine material:
>
> --Oral polio; up to 1988, foetal calf serum was used from UK and New
> Zealand (pooled); since 1988 foetal calf serum only from New Zealand.
> Large stocks are held.
>
> --Rubella; bulk was made before 1979 from foetal calf serum from UK
> and New Zealand. None has been made as there are some 15 years stock.
>
> --Diphtheria; UK bovine beef muscle and ox heart is used but since the
> end of 1988 this has been sourced from Eire. There are 1,250 litres
> of stock.
>
> --Tetanus; this involves bovine material from the UK mainly Scottish.
> There are 21,000 litres of stock.
>
> --Pertussis; uses bovine material from the UK. There are 63,000 litres
> of stock.
>
> --They consider that to switch to a non-UK source will take a minimum
> of 6-18 months and to switch to a non-bovine source will take a minimum
> of five years.
>
> 3. XXXXXXXXXXX have measles, mumps, MMR, rubella vaccines. These are
> sourced from the USA and the company believes that US material only is
> used.
>
> 89/2.14/2.1
> ============
>
> BSE3/1 0251
>
> 4. XXXXXXXXXXX have a measles vaccine using bovine serum from the UK.
> there are 440,000 units of stock.
> --They have also got MMR using bovine serum from the UK.
>
> 5. XXXXXXXXXXX have influenza, rubella, measles, MMR vaccines likely to
> be used in children. Of those they think that only MMR contains bovine
> material which is probably a French origin.
>
> 6. XXXXXXXXXXX have diphtheria/tetanus and potasses on clinical trial.
> These use veal material, some of which has come from the UK and has
> been made by XXXXXXXXXXX (see above).
>
> 7. XXXXXXXXXXX have influenza vaccines which are made up in egg medium.
>
> 8. XXXXXXXXXXX The Secretary of State has a number of licences. We
> understand that the inactivated polio vaccine is no longer being used.
> There is a stock of smallpox vaccine. We have not been able to determine
> the source material. (Made in sheep very unlikely to certain bovine
> ingredients).
>
> 9. XXXXXXXXXXX have acellular triple vaccine in which material of
> UK bovine source has been used.
>
> As far as I can see, XXXXXXXXXXX are the sole supplier of pertussis
> vaccine which uses bovine casein digest.
>
> You should also be aware that DH has made arrangements for meningococal
> vaccine to be available, on a named patient basis, from
> XXXXXXXXXXX and XXXXXXXXXXX. Both companies use bovine media in
> production.
>
> Expert Group Meetings
>
> The Veterinary Products Conmmittee will discuss the proposed draft
> guidelines and significance thereof to veterinary vaccine products
> at 2.00pm on Thursday 16 February 1989 with professor Armo in the
> Chair. (See appendix for VPC Committee constitution).
>
> The Human & Veterinary Medicines Working Group re BSE will meet on
> 22 February at 10.00am Market Towers. The meeting will be to provide
> expert information to CSM on the 23 February in the light of the
> Southwood report and concerns about vaccines. In addition to Department
> of Health and MAFF officials, Professor Collee, Dr Schild, Dr Minor,
> Dr Tyrell from the Biologicals Subcommittee will be present,
> Dr Kimberlin and Dr Martin and Mr Wilesmith have been invited.
> Professor Collee will be in the Chair.
>
> The Committee on Safety of Medicines will meet on the 23 February. They
> will consider advice from the working group, draft guidelines for the
> industry, a draft letter to product licence holders of human medicines,
> and recommendations regarding priority actions on particular product
> groups.
>
> MAFF briefing note is added at Appendix 6.
>
> DR P N ADAMS
>
> 89/2.14/
> =========
> TSS

http://www.whale.to/v/singeltary7.html

http://www.whale.to/v/cjd2.html

THEN they finally became availabel online at BSE Inquiry;

-------- Original Message --------
Subject: Transmissible Spongiform Encephalopathies Advisory Committee
Date: Fri, 8 Oct 2004 14:30:09 -0500
From: "Terry S. Singeltary Sr."
Reply-To: Bovine Spongiform Encephalopathy
To: BSE-L@UNI-KARLSRUHE.DE

##################### Bovine Spongiform Encephalopathy #####################

-------- Original Message --------
Subject: Transmissible Spongiform Encephalopathies Advisory Committee
Date: Wed, 06 Oct 2004 21:21:44 -0500
From: "Terry S. Singeltary Sr."
To: "Freas, William"
CC: "Langford, Sheila" , "Smallwood, Linda"

References: <2185E187D9585E40B796B256F5AA60B601AF9706@cbsms05.cber.fda.gov>


ALSO

Subject: Transmissible Spongiform Encephalopathies Advisory Committee;
[FR Doc. 04-21282 Filed 9-21-04; 8:45 am] (TSS SUB. short version 10/4/04)
Date: Fri, 08 Oct 2004 08:13:58 -0500
From: "Terry S. Singeltary Sr."
To: fdadockets@oc.fda.gov

Transmissible Spongiform Encephalopathies Advisory Committee;
[FR Doc. 04-21282 Filed 9-21-04; 8:45 am] (TSS SUB. short version 10/4/04)

Greetings Dr. Freas, Dr. Langford, Dr. Smallwood and all FDA,

I WISH to make the following submission and comments about all
topics of this meeting about human/animal TSEs. My comments and
submissions as follows please;

>>>>USDA-licensed tests for the diagnosis of bovine
>>>>spongiform encephalopathy (BSE) and other transmissible spongiform
>>>>encephalopathies (TSE),
>>
>>


IN the past all we have heard is the fact that the present BSEs test
do not guarantee public health safety. I request that the USA implement a
BSE/TSE test that DOES guarantee public health safety, one approved for
consumer
protection, a test for live cattle, one that would detect all TSEs in the
bovine, one that would detect sub clinical TSEs; EFSA Scientific Report
on the Design of a Field Trial Protocol for the Evaluation of BSE Tests for
Live Cattle This report provides a protocol for the design
of a field trial protocol for the evaluation of BSE tests for live cattle
for the purpose of consumer protection only.
Publication date: 17 September 2004
Adopted on 1 July 2004

http://www.efsa.eu.int/science/efsa_scientific_reports/bse_tse/612_en.html


>>>> review of the worldwide BSE situation,
>>
>>


THE most disturbing factor of this topic are the new atypical TSEs
showing up in not only cattle, but also sheep, and no one knows yet
about how many different strains of cwdTSE in deer/elk. WITH evidence of
sporadic CJD being very similar to these atypical TSEs in cattle and sheep,
and the findings from Asante, Collinge et al that BSE prions propagate
as either nvCJD or sporadic CJD, the ramifications of these findings are
very very worrisome and should not go ignored any further. WITH
the fact that there are over 20 documented strains of scrapie, and the
most logical hypothesis is scrapie to BSE, why would one believe in
only one phenotype of TSE in the bovine. IN fact, we have a new study
of two distinct prion strains derived from BSE in mice. YOU must not
continue to ignore these studies;

BSE prions propagate as either variant CJD-like or sporadic CJD-like
prion strains in transgenic mice expressing human prion protein

http://embojournal.npgjournals.com/cgi/content/full/21/23/6358

THE new findings of BASE in cattle in Italy of Identification of a
second bovine amyloidotic spongiform encephalopathy: Molecular
similarities with sporadic Creutzfeldt-Jakob disease

http://www.pnas.org/cgi/content/abstract/0305777101v1

Characterization of two distinct prion strains
derived from bovine spongiform encephalopathy
transmissions to inbred mice

http://vir.sgmjournals.org/cgi/content/abstract/85/8/2471

Adaptation of the bovine spongiform encephalopathy agent to primates
and comparison with Creutzfeldt-Jakob disease: Implications for
human health

http://www.pnas.org/cgi/content/full/041490898v1

In an experimental study of the transmissibility of BSE to the pig,
seven of 10 pigs, infected at 1-2 weeks of age by multiple-route
parenteral inoculation with a homogenate of bovine brain from
natural BSE cases developed lesions typical of spongiform
encephalopathy...

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=10684682&dopt=Abstract

THE recent discoveries of previously unidentified strains of
Scrapie such as 221C44 and the Nor9845;

FULL TEXT APPRX. 91 PAGES

UK Strategy for Research and
Development on Human and Animal
Health Aspects of Transmissible
Spongiform Encephalopathies

2004-2007

http://www.mrc.ac.uk/pdf-uk_strategy_v5.2.pdf

WHEN in fact, the findings from Marsh and the findings at
MISSION, TEXAS support even further evidence that there
are further strains of TSE in the USA besides that one
accidentally documented BSE case in Washington on
Dec. 23, 2003;

In Confidence - Perceptions of unconventional slow virus diseases of
animals in the USA - Report of a visit to the USA - April-May 1989 - G A H
Wells [head of England's main veterinary lab]

http://www.bseinquiry.gov.uk/files/mb/m11b/tab01.pdf

Evidence That Transmissible Mink Encephalopathy
Results from Feeding Infected Cattle

http://www.bseinquiry.gov.uk/files/mb/m09/tab05.pdf

>>
>
>
>>>>labeling claims for TSE clearance studies for plasma derivative
>>>>products.
>>>>
>>
>>
>>
>>
>
>
>>>>The committee will then discuss and make recommendations
>>>>regarding presumptive transfusion transmissions of variant Creutzfeldt
>>>>Jakob Disease (vCJD) and current FDA-recommended safeguards.
>>>>
>>
>>
>>
>>
>
>


ONE of the things i have been most worried about and will continue to
bring to the attention of the TSE advisory committee is the continued
denial of the potential of transmission of sporadic CJD via blood and
blood products. THERE are studies showing infectivity in the blood of
sporadic CJD, and just how many phenotypes there are of sporadic CJD is
anyone's guess at this point in time. WE have already documented
transmission of sporadic CJD via tissues and organs. TO continue the
BSE/nvCJD only theory will only continue to spread this agent. WE must
move away from this mentality and move on with all TSEs and treat all
TSEs as one, until proven otherwise, not the other way around. with
6,000 'DEAR nvCJD LETTERS' due to blood and blood products so far, i can
only imagine the number, once sporadic CJD is documented to have
transmitted via blood, what that number will be when those 'DEAR
SPORADIC CJD LETTERS' go out and how many will become clinical once
exposed, a frightening thought. OR, has infection by sporadic CJD
already happened, i don't think they are too sure if the 2nd
_infection_ of CJD was sporadic or variant;

Summary of SEACs discussion on the second presumed case of blood
transfusion-associated infection with vCJD


>> 7. SEAC agreed that the western blot results and glycotype profile
>> suggested it was unlikely that the infection was preclinical sporadic
>> CJD (sCJD). The committee noted that a single study by Glatzel et al
>> (2003) had reported PrPres in the spleen of sCJD clinical cases.
>> However, the levels of PrPres present in sCJD cases were low and
>> detected in patients with a lengthy clinical illness from sporadic CJD.
>
>


http://www.seac.gov.uk/statements/state070804.htm

vCJD: Blood Transfusion Incident

http://www.publications.parliament.uk/pa/ld199697/ldhansrd/pdvn/lds03/text/3
1217-09.htm

MOST importantly, the 1968 MEDICINES ACT where it states 'NO SAF' was
blatantly ignored,
for animals and humans.

http://www.bseinquiry.gov.uk/files/yb/1983/06/00001001.pdf

8. The Secretary of State has a number of licences. We understand that
the inactivated polio vaccine is no longer being used. There is a stock
of smallpox vaccine. We have not been able to determine the source
material. (Made in sheep very unlikely to contain bovine ingredients).

http://www.bseinquiry.gov.uk/files/yb/1989/02/14010001.pdf

http://www.bseinquiry.gov.uk/report/volume7/chapted2.htm

http://www.bseinquiry.gov.uk/files/yb/1989/02/14011001.pdf

although 176 products do _not_ conform to the CSM/VPC
guidelines.

http://www.bseinquiry.gov.uk/files/yb/1989/09/06011001.pdf

IMPORTS OF POTENTIALLY TAINTED BIOLOGICAL PRODUCTS TO USA

3002.20.0000: VACCINES FOR HUMAN MEDICINE

U.S. Imports for Consumption: December 1998 and 1998 Year-to-Date
(Customs Value, in Thousands of Dollars)
(Units of Quantity: Kilograms)

<--- Dec 1998 ---> <--- 1998 YTD --->
Country Quantity Value Quantity Value
=================================================================
WORLD TOTAL . . . . . . . 25,702 26,150 550,258 378,735
Austria . . . . . . . . . --- --- 45 225
Belgium . . . . . . . . . 14,311 12,029 248,041 199,036
Canada . . . . . . . . . 1,109 1,527 15,798 16,305
Denmark . . . . . . . . . 80 234 246 682
Federal Rep. of Germany 1,064 4,073 12,001 6,329
France . . . . . . . . . 3,902 4,859 87,879 92,845
Ireland . . . . . . . . . --- --- 120 478
Italy . . . . . . . . . . --- --- 2,359 81
Japan . . . . . . . . . . 445 1,903 11,350 11,298
Netherlands . . . . . . . --- --- 94 6
Republic Of South Africa --- --- 2 1
Spain . . . . . . . . . . --- --- 60 30
Switzerland . . . . . . . 716 353 9,303 4,271
United Kingdom . . . . . 4,075 1,172 162,960 47,148

http://www.ita.doc.gov/industry/otea/Trade-Detail/Latest-December/Imports/30
/300230.html

FULL TEXT PARTIAL LISTING

http://www.mad-cow.org/00/jul00_dont_eat_sheep.html#hhh

Transmissible encephalopathies and biopharmaceutical production.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9119144&dopt=Abstract

Blood donated after vaccination with rabies vaccine derived from sheep brain
cells might transmit CJD

http://bmj.bmjjournals.com/cgi/content/full/313/7069/1405/a

Blood to be screened for CJD

http://bmj.bmjjournals.com/cgi/content/full/313/7055/441

***Similar levels of infectivity in the blood of mice infected with
human-derived vCJD and GSS strains of transmissible spongiform
encephalopathy***

http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0041-1132&date=2003&volume=43&issue=12&spage=1687

Spongiform encephalopathy transmitted experimentally from
Creutzfeldt-Jakob and familial Gerstmann-Straussler-Scheinker diseases.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2276050

Lancet 2000; 356: 955 - 956

snip...

Blood from four of 37 human beings with clinically evident sporadic CJD has
been
reported to transmit the disease after intracerebral inoculation into
guineapigs,
mice, or hamsters. But each success has been questioned on technical grounds
and has not been reproducible;

http://www.thelancet.com/

Transmission of Creutzfeldt-Jakob Disease from Blood and Urine Into Mice

The Lancet, November 9, 1985

Sir,--Professor Manuelidis and his colleagues (Oct 19, p896) report
transmission to animals of Creutzfeldt-Jakob disease (CJD) from the
buffy coat from two patients. We also transmitted the disease from
whole blood samples of a patient (and of mice) infected with CJD.1
Brain, Cornea, and urine from this patient were also infectious, and
the clinicopathological findings2 are summarised as follows.

snip...

Department of Neuropathology,
Neurological Institute,
Faculty of Medicine,
Kyushu University,
Fukuoka812, Japan

JUN TATEISHI

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=2865558&dopt=Citation

This observation represents the first documented transmission of BSE
from the blood of an experimentally infected primate...

http://www.blackwell-synergy.com/servlet/useragent?func=synergy&synergyAction=showAbstract&doi=10.1046/j.1537-2995.2002.00098.x

Transmission of prion diseases by blood transfusion

Nora Hunter,1 James Foster,1 Angela Chong,1 Sandra McCutcheon,2 David
Parnham,1 Samantha Eaton,1 Calum MacKenzie1 and Fiona Houston2

see full text;

http://www.socgenmicrobiol.org.uk/JGVDirect/18580/18580ft.pdf

THEN one must consider these new findings of ;

Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt-Jakob Disease

snip...

Conclusions Using sensitive techniques, we identified extraneural
deposition
of PrPSc in spleen and muscle samples from approximately one third of
patients
who died with sporadic Creutzfeldt-Jakob disease. Extraneural PrPSc appears
to correlate with a long duration of disease.

http://content.nejm.org/cgi/content/short/349/19/1812?query=TOC

Prions in skeletal muscle (Prusiner et al)

http://www.pnas.org/cgi/doi/10.1073/pnas.052707499

EMBO reports AOP Published online: 11 April 2003 Widespread PrPSc
accumulation in muscles of hamsters orally infected with scrapie

http://www.emboreports.org/

How much is too much? How much is not enough? What about accumulation?
What is the Threshold of exposure, to infectivity, to clinical disease?
How many strains/phenotype does sporadic CJD consist of and
What is the infectivity of each one of those phenotypes (cwdCJD)?
Until these questions are answered, you are gambling, nothing more.
I just pray that you get it right...

ALL human/animal TSEs should be made reportable Nationally and
Internationally.
ALL human TSE victims (family) should fill out mandatory CJD Questionnaire.

thank you,

Terry S. Singeltary Sr.
P.O. Box 42
Bacliff, Texas USA 77518

################# BSE-L-subscribe-request@uni-karlsruhe.de #################

BSE-L Archives  November 1999


1. Re:

(74 lines)
From: Roland Heynkes
Date: Fri, 12 Nov 1999 08:57:49 +0100
2. "Alternative splicing" across prion-doppel tandem duplication
* "Alternative splicing" across prion-doppel tandem
duplication

(86 lines)
From: tom
Date: Mon, 29 Nov 1999 13:33:10 -0700
3. "Non-invasive test for BSE n live cattle"
* "Non-invasive test for BSE n live cattle"

(70 lines)
From: J Ralph Blanchfield
Date: Thu, 4 Nov 1999 12:06:50 +0000
* Re: "Non-invasive test for BSE n live cattle"

(79 lines)
From: Paul Eduard Schenker


Date: Thu, 4 Nov 1999 23:28:47 +0800
4. 26-th case in France
* 26-th case in France

(66 lines)
From: Maurizio Ottaviani
Date: Wed, 24 Nov 1999 11:58:47 +0100
5. 8 new prion mutants found: T188R and P238S
* 8 new prion mutants found: T188R and P238S

(413 lines)
From: tom
Date: Mon, 22 Nov 1999 12:50:21 -0700
6.
*

(40 lines)
From: Kerstin
Date: Thu, 11 Nov 1999 14:11:49 +0200
7. A french new case
* A french new case

(31 lines)
From: Yves Le Pape
Date: Tue, 23 Nov 1999 12:03:46 +0100
8. a map of BSE in France
* a map of BSE in France

(33 lines)
From: Marc Barbier
Date: Mon, 15 Nov 1999 10:11:46 +0100
9. A plea: trim replies, dump the HTML
* A plea: trim replies, dump the HTML

(77 lines)
From: Charles Arthur, The Independent

Date: Mon, 29 Nov 1999 10:30:33 +0000
* Re: A plea: trim replies, dump the HTML

(55 lines)
From: E.C.Apling
Date: Mon, 29 Nov 1999 19:20:42 -0000
* Re: A plea: trim replies, dump the HTML

(52 lines)
From: Roland Heynkes
Date: Tue, 30 Nov 1999 10:01:38 +0100
* Re: A plea: trim replies, dump the HTML

(69 lines)
From: Charles Arthur, The Independent

Date: Tue, 30 Nov 1999 12:35:00 +0000
10. A Reply to the BMJ article, by Bart Van Everbroeck
* A Reply to the BMJ article, by Bart Van Everbroeck

(29 lines)
From: Terry S. Singeltary Sr.
Date: Sun, 14 Nov 1999 11:32:21 -0600
11. About Epidemiosurveillance network Efficiency
* About Epidemiosurveillance network Efficiency

(216 lines)
From: Marc Barbier
Date: Thu, 18 Nov 1999 10:35:52 +0100
* Re: About Epidemiosurveillance network Efficiency

(79 lines)
From: tom
Date: Thu, 18 Nov 1999 08:32:50 -0700
12. Acinetobacter Again
* Acinetobacter Again

(75 lines)
From: Rachel Shepherd
Date: Mon, 1 Nov 1999 19:47:01 PST
13. Alice-in-Wonderland at TSE blood meeting Feb 13 DC
* Alice-in-Wonderland at TSE blood meeting Feb 13 DC

(87 lines)
From: tom
Date: Tue, 23 Nov 1999 14:12:00 -0700
14. another British lion down from BSE
* another British lion down from BSE

(69 lines)
From: tom
Date: Thu, 4 Nov 1999 16:59:34 -0700
15. Another case of madcow disease in France...
* Another case of madcow disease in France...

(64 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 23 Nov 1999 08:08:20 -0600
16. article about BSE test
* article about BSE test

(135 lines)
From: helene rudyk
Date: Thu, 11 Nov 1999 09:46:39 +0000
* Re: article about BSE test

(133 lines)
From: Roland Heynkes
Date: Fri, 12 Nov 1999 09:44:44 +0100
* Re: article about BSE test

(68 lines)
From: tom
Date: Fri, 12 Nov 1999 09:42:35 -0700
17. Baby Food * June 23, 1999 BSE Inquiry
* Baby Food * June 23, 1999 BSE Inquiry

(147 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 30 Nov 1999 11:16:54 -0600
18. BSE * Downer cattle in Switzerland; re-Robert and Roland
* BSE * Downer cattle in Switzerland; re-Robert and Roland

(57 lines)
From: Terry S. Singeltary Sr.
Date: Fri, 12 Nov 1999 16:07:01 -0600
* Re: BSE * Downer cattle in Switzerland; re-Robert and Roland

(57 lines)
From: Robert A. LaBudde
Date: Fri, 12 Nov 1999 21:17:20 -0500
* Re: BSE * Downer cattle in Switzerland; re-Robert and Roland

(71 lines)
From: Torsten Brinch
Date: Sat, 13 Nov 1999 10:31:57 +0100
* Re: BSE * Downer cattle in Switzerland; re-Robert and Roland

(101 lines)
From: Terry S. Singeltary Sr.
Date: Sat, 13 Nov 1999 09:37:01 -0600
19. BSE * new cases - Switzerland
* BSE * new cases - Switzerland

(87 lines)
From: Terry S. Singeltary Sr.
Date: Sat, 13 Nov 1999 15:08:33 -0600
20. BSE France
* BSE France

(49 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 9 Nov 1999 13:32:29 -0600
* Re: BSE France

(41 lines)
From: Roland Heynkes
Date: Wed, 10 Nov 1999 09:35:17 +0100
* Re: BSE France

(51 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 10 Nov 1999 09:48:07 -0600
* Re: BSE France

(46 lines)
From: Torsten Brinch
Date: Sat, 13 Nov 1999 19:02:33 +0100
* Re: BSE France

(58 lines)
From: Vincent Dedet
Date: Tue, 16 Nov 1999 17:14:23 +0100
* Re: BSE France

(146 lines)
From: Marcus Doherr
Date: Tue, 16 Nov 1999 17:34:57 +0100
* Re: BSE France

(116 lines)
From: Markus Moser
Date: Tue, 16 Nov 1999 19:03:29 +0100
* Re: BSE France

(38 lines)
From: Torsten Brinch
Date: Tue, 16 Nov 1999 19:51:16 +0100
* Re: BSE France

(41 lines)
From: Roland Heynkes
Date: Wed, 17 Nov 1999 08:56:24 +0100
21. BSE France / Swiss BSE Surveillance
* Re: BSE France / Swiss BSE Surveillance

(156 lines)
From: Markus Moser
Date: Wed, 17 Nov 1999 14:02:47 +0100
* Re: BSE France / Swiss BSE Surveillance

(178 lines)
From: Roland Heynkes
Date: Thu, 18 Nov 1999 02:09:54 +0100
22. BSE in downer cattle
* Re: BSE in downer cattle

(61 lines)
From: Robert A. LaBudde
Date: Thu, 11 Nov 1999 22:22:17 -0500
23. BSE Switzerland
* BSE Switzerland

(42 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 9 Nov 1999 08:24:42 -0600
* Re: BSE Switzerland

(55 lines)
From: Vincent Dedet
Date: Tue, 9 Nov 1999 16:05:53 +0100
* Re: BSE Switzerland

(88 lines)
From: Robert A. LaBudde
Date: Tue, 9 Nov 1999 11:12:36 -0500
* Re: BSE Switzerland

(162 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 9 Nov 1999 20:13:56 -0600
* Re: BSE Switzerland

(46 lines)
From: Roland Heynkes
Date: Wed, 10 Nov 1999 08:37:15 +0100
* Re: BSE Switzerland

(97 lines)
From: Roland Heynkes
Date: Wed, 10 Nov 1999 09:02:14 +0100
* Re: BSE Switzerland

(149 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 10 Nov 1999 09:24:34 -0600
* Re: BSE Switzerland

(91 lines)
From: Robert A. LaBudde
Date: Wed, 10 Nov 1999 12:55:04 -0500
* Re: BSE Switzerland

(48 lines)
From: Robert A. LaBudde
Date: Wed, 10 Nov 1999 12:59:28 -0500
* Re: BSE Switzerland

(50 lines)
From: Roland Heynkes
Date: Wed, 10 Nov 1999 20:27:32 +0100
* Re: BSE Switzerland

(134 lines)
From: Roland Heynkes
Date: Wed, 10 Nov 1999 22:45:17 +0100
* Re: BSE Switzerland

(96 lines)
From: Robert A. LaBudde
Date: Wed, 10 Nov 1999 23:33:59 -0500
* Re: BSE Switzerland

(132 lines)
From: Roland Heynkes
Date: Thu, 11 Nov 1999 20:58:24 +0100
* Re: BSE Switzerland

(48 lines)
From: tom
Date: Thu, 11 Nov 1999 14:44:05 -0700
* Re: BSE Switzerland

(59 lines)
From: Roland Heynkes
Date: Fri, 12 Nov 1999 06:53:08 +0100
24. BSE, U.K problem, European Problem, or ?
* BSE, U.K problem, European Problem, or ?

(38 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 9 Nov 1999 21:23:01 -0600
25. CHI TSE Meeting DC: Prion receptor found
* CHI TSE Meeting DC: Prion receptor found

(87 lines)
From: Bossers, A.
Date: Wed, 3 Nov 1999 11:21:04 +0100
* Re: CHI TSE Meeting DC: Prion receptor found

(34 lines)
From: Rachel Shepherd
Date: Wed, 3 Nov 1999 21:36:14 PST
26. DFA 18 Cosmetics...[There have been reports of BSE outbreaks in
Germany, France, and even in the U.S.A., a prime market for Jersey
cattle]
* DFA 18 Cosmetics...[There have been reports of BSE outbreaks
in Germany, France, and even in the U.S.A., a prime market
for Jersey cattle]

(90 lines)
From: Terry S. Singeltary Sr.
Date: Mon, 1 Nov 1999 09:28:04 -0600
* Re: DFA 18 Cosmetics...[There have been reports of BSE
outbreaks in Germany, France, and even in the U.S.A., a
prime market for Jersey cattle]

(74 lines)
From: Roland Heynkes
Date: Tue, 2 Nov 1999 00:22:07 +0100
27. DFA 18 Cosmetics...[There have been reports of BSEoutbreaks in
Germany, France, and even in the U.S.A.,a prime market for Jersey
cattle]
* Re: DFA 18 Cosmetics...[There have been reports of
BSEoutbreaks in Germany, France, and even in the U.S.A.,a
prime market for Jersey cattle]

(142 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 2 Nov 1999 11:49:56 -0600
* Re: DFA 18 Cosmetics...[There have been reports of
BSEoutbreaks in Germany, France, and even in the U.S.A.,a
prime market for Jersey cattle]

(127 lines)
From: Roland Heynkes
Date: Wed, 3 Nov 1999 00:07:05 +0100
28. DFA 18 Cosmetics...[There have been reports ofBSEoutbreaks in
Germany, France,and even in the U.S.A.,a prime market for Jersey
cattle]
* Re: DFA 18 Cosmetics...[There have been reports
ofBSEoutbreaks in Germany, France,and even in the U.S.A.,a
prime market for Jersey cattle]

(141 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 3 Nov 1999 08:36:15 -0600
* Re: DFA 18 Cosmetics...[There have been reports
ofBSEoutbreaks in Germany, France,and even in the U.S.A.,a
prime market for Jersey cattle]

(68 lines)
From: Roland Heynkes
Date: Wed, 3 Nov 1999 20:37:30 +0100
29. DFA 18 Cosmetics...[There have been reportsofBSEoutbreaks in
Germany,France,and even in the U.S.A.,a prime market for Jersey
cattle]
* Re: DFA 18 Cosmetics...[There have been
reportsofBSEoutbreaks in Germany,France,and even in the
U.S.A.,a prime market for Jersey cattle]

(80 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 3 Nov 1999 20:31:48 -0600
30. Diagnostic tests for TSE's
* Diagnostic tests for TSE's

(69 lines)
From: Terry S. Singeltary Sr.
Date: Fri, 12 Nov 1999 16:42:02 -0600
31. eBMJ -- eLetters for , 319 (7220) 1312

* Re: eBMJ -- eLetters for , 319 (7220) 1312


(555 lines)
From: Terry S. Singeltary Sr.
Date: Sun, 14 Nov 1999 11:40:29 -0600
32. EU SSC Minutes of meeting 28-29 October 1999
* EU SSC Minutes of meeting 28-29 October 1999

(1165 lines)
From: J Ralph Blanchfield
Date: Thu, 4 Nov 1999 11:04:58 +0000
33. eyewitness account of Inquiry
* eyewitness account of Inquiry

(94 lines)
From: tom
Date: Wed, 17 Nov 1999 18:39:49 -0700
* Re: eyewitness account of Inquiry

(127 lines)
From: Rachel Shepherd
Date: Thu, 18 Nov 1999 17:07:51 PST
* Re: eyewitness account of Inquiry

(186 lines)
From: Terry S. Singeltary Sr.
Date: Fri, 19 Nov 1999 09:40:57 -0600
* Re: eyewitness account of Inquiry

(62 lines)
From: Roland Heynkes
Date: Sat, 20 Nov 1999 11:53:40 +0100
34. FDA 23 Nov 99 Blood Donation Guidelines for CJD
* FDA 23 Nov 99 Blood Donation Guidelines for CJD

(714 lines)
From: tom
Date: Sun, 28 Nov 1999 20:52:32 -0700
35. First case of CWD in Montana...
* First case of CWD in Montana...

(107 lines)
From: Terry S. Singeltary Sr.
Date: Mon, 8 Nov 1999 13:09:20 -0600
* Re: First case of CWD in Montana...

(138 lines)
From: Terry S. Singeltary Sr.
Date: Mon, 8 Nov 1999 14:09:15 -0600
36. Flexible region 104-113 studied by epitope-antibody xray
* Flexible region 104-113 studied by epitope-antibody xray

(96 lines)
From: tom
Date: Tue, 2 Nov 1999 13:39:47 -0700
37. French say "Beef Ban must stay" "We will Not move"
* French say "Beef Ban must stay" "We will Not move"

(40 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 10 Nov 1999 21:37:36 -0600
38. Girl, 13, could be youngest BSE case
* Girl, 13, could be youngest BSE case

(99 lines)
From: tom
Date: Tue, 23 Nov 1999 14:38:18 -0700
* Re: Girl, 13, could be youngest BSE case

(116 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 24 Nov 1999 10:18:39 -0600
* Re: Girl, 13, could be youngest BSE case

(36 lines)
From: Roland Heynkes
Date: Fri, 26 Nov 1999 00:29:44 +0100
* Re: Girl, 13, could be youngest BSE case

(56 lines)
From: Terry S. Singeltary Sr.
Date: Fri, 26 Nov 1999 10:54:41 -0600
* Re: Girl, 13, could be youngest BSE case

(58 lines)
From: Roland Heynkes
Date: Fri, 26 Nov 1999 22:37:08 +0100
* Re: Girl, 13, could be youngest BSE case

(217 lines)
From: Terry S. Singeltary Sr.
Date: Fri, 26 Nov 1999 21:27:12 -0600
* Re: Girl, 13, could be youngest BSE case

(227 lines)
From: Univ.-Prof.Dr.Herbert Budka
Date: Sat, 27 Nov 1999 12:28:31 +0100
* Re: Girl, 13, could be youngest BSE case

(115 lines)
From: Terry S. Singeltary Sr.
Date: Sat, 27 Nov 1999 10:12:21 -0600
* Re: Girl, 13, could be youngest BSE case

(49 lines)
From: Roland Heynkes
Date: Sun, 28 Nov 1999 09:18:50 +0100
* Re: Girl, 13, could be youngest BSE case

(57 lines)
From: Roland Heynkes
Date: Sun, 28 Nov 1999 14:07:20 +0100
* Re: Girl, 13, could be youngest BSE case

(37 lines)
From: Terry S. Singeltary Sr.
Date: Sun, 28 Nov 1999 16:17:42 -0600
* Re: Girl, 13, could be youngest BSE case

(76 lines)
From: Univ.-Prof.Dr.Herbert Budka
Date: Mon, 29 Nov 1999 16:31:24 +0100
39. Girl, 13, shows CJD symptoms.
* Girl, 13, shows CJD symptoms.

(80 lines)
From: Debora MacKenzie
Date: Tue, 23 Nov 1999 23:05:33 +0100
* Re: Girl, 13, shows CJD symptoms.

(90 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 24 Nov 1999 11:35:44 -0600
* Re: Girl, 13, shows CJD symptoms.

(55 lines)
From: Robert A. LaBudde
Date: Thu, 25 Nov 1999 06:30:22 -0500
40. Girl, 13, shows CJD symptoms. [re-baby food]
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(90 lines)
From: Terry S. Singeltary Sr.
Date: Thu, 25 Nov 1999 11:21:52 -0600
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(82 lines)
From: Robert A. LaBudde
Date: Thu, 25 Nov 1999 13:17:45 -0500
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(214 lines)
From: J Ralph Blanchfield
Date: Thu, 25 Nov 1999 22:30:36 +0000
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(47 lines)
From: Roland Heynkes
Date: Fri, 26 Nov 1999 00:27:17 +0100
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(50 lines)
From: Rachel Shepherd
Date: Thu, 25 Nov 1999 15:41:51 PST
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(42 lines)
From: Tim Sly
Date: Thu, 25 Nov 1999 22:12:01 -0500
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(48 lines)
From: Roland Heynkes
Date: Fri, 26 Nov 1999 10:04:47 +0100
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(60 lines)
From: Roland Heynkes
Date: Fri, 26 Nov 1999 10:15:47 +0100
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(303 lines)
From: Terry S. Singeltary Sr.
Date: Fri, 26 Nov 1999 10:36:34 -0600
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(84 lines)
From: Robert A. LaBudde
Date: Fri, 26 Nov 1999 17:36:12 -0500
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(100 lines)
From: Tam Garland
Date: Fri, 26 Nov 1999 16:47:54 -0600
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(402 lines)
From: J Ralph Blanchfield
Date: Sat, 27 Nov 1999 12:03:22 +0000
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(588 lines)
From: Terry S. Singeltary Sr.
Date: Sat, 27 Nov 1999 18:54:39 -0600
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(179 lines)
From: J Ralph Blanchfield
Date: Sun, 28 Nov 1999 11:46:07 +0000
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(79 lines)
From: Roland Heynkes
Date: Sun, 28 Nov 1999 16:43:01 +0100
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(55 lines)
From: Rachel Shepherd
Date: Sun, 28 Nov 1999 15:12:27 PST
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(73 lines)
From: Torsten Brinch
Date: Mon, 29 Nov 1999 14:06:54 +0100
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(69 lines)
From: Roland Heynkes
Date: Mon, 29 Nov 1999 07:24:48 +0100
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(64 lines)
From: Rachel Shepherd
Date: Mon, 29 Nov 1999 19:44:26 PST
* Re: Girl, 13, shows CJD symptoms. [re-baby food]

(95 lines)
From: Roland Heynkes
Date: Tue, 30 Nov 1999 22:56:04 +0100
41. Glycosylation differences between the normal and pathogenic prion
* Glycosylation differences between the normal and pathogenic
prion

(371 lines)
From: tom
Date: Tue, 9 Nov 1999 12:50:03 -0700
42. Hidden BSE
* Re: Hidden BSE

(155 lines)
From: Marcus Doherr
Date: Mon, 1 Nov 1999 10:09:43 +0100
* Re: Hidden BSE

(119 lines)
From: tom
Date: Mon, 1 Nov 1999 07:30:56 -0700
43. ladies rubbing cow brain or placenta on to their faces
* ladies rubbing cow brain or placenta on to their faces

(60 lines)
From: tom
Date: Wed, 3 Nov 1999 22:24:24 -0700
44. Lancet editor threatened by Royal Society food reps
* Lancet editor threatened by Royal Society food reps

(195 lines)
From: tom
Date: Tue, 2 Nov 1999 07:09:54 -0700
45. links not working
* links not working

(47 lines)
From: tom
Date: Sun, 21 Nov 1999 13:48:10 -0700
46. Mad Cow Disease: The Risk of the U.S. PCRM-Health
* Mad Cow Disease: The Risk of the U.S. PCRM-Health

(787 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 30 Nov 1999 15:19:07 -0600
47. Monthly UK CJD figures, issued Nov. 1, 1999
* Monthly UK CJD figures, issued Nov. 1, 1999

(37 lines)
From: Terry S. Singeltary Sr.
Date: Mon, 1 Nov 1999 11:13:07 -0600
48. nvCJD reach 49
* nvCJD reach 49

(57 lines)
From: tom
Date: Mon, 1 Nov 1999 10:39:33 -0700
* Re: nvCJD reach 49

(75 lines)
From: Charles Arthur, The Independent

Date: Fri, 12 Nov 1999 14:01:03 +0100
* Re: nvCJD reach 49

(48 lines)
From: Neil McLennan
Date: Fri, 12 Nov 1999 14:13:36 +0000
* Re: nvCJD reach 49

(85 lines)
From: tom
Date: Fri, 12 Nov 1999 08:18:50 -0700
* Re: nvCJD reach 49

(105 lines)
From: Neil McLennan
Date: Wed, 17 Nov 1999 12:12:22 +0000
* Re: nvCJD reach 49

(43 lines)
From: Roland Heynkes
Date: Sat, 20 Nov 1999 12:06:58 +0100
* Re: nvCJD reach 49

(80 lines)
From: Neil McLennan
Date: Sat, 20 Nov 1999 13:27:42 +0000
* Re: nvCJD reach 49

(94 lines)
From: Roland Heynkes
Date: Sat, 20 Nov 1999 18:56:19 +0100
* Re: nvCJD reach 49

(133 lines)
From: tom
Date: Sat, 20 Nov 1999 14:47:03 -0700
49. Pediatric forms of Creutzfeldt-Jakob disease
* Pediatric forms of Creutzfeldt-Jakob disease

(114 lines)
From: tom
Date: Sun, 28 Nov 1999 20:46:08 -0700
50. please send confirmation of e-mail address...
* please send confirmation of e-mail address...

(31 lines)
From: DR.HARSH SADANA
Date: Wed, 10 Nov 1999 17:46:46 +0530
* Re: please send confirmation of e-mail address...

(51 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 10 Nov 1999 08:19:33 -0600
51. Prion Classification
* Re: Prion Classification

(111 lines)
From: Roland Heynkes
Date: Mon, 1 Nov 1999 08:02:02 +0100
52. Prion receptor at Caprion
* Prion receptor at Caprion

(187 lines)
From: tom
Date: Wed, 3 Nov 1999 08:49:06 -0700
53. Protocadherin backgrounder
* Protocadherin backgrounder

(238 lines)
From: tom
Date: Wed, 3 Nov 1999 10:05:25 -0700
54. PrpC upregulated adjacent to skin ulcerations
* PrpC upregulated adjacent to skin ulcerations

(85 lines)
From: tom
Date: Fri, 12 Nov 1999 10:26:27 -0700
55. re-BSE France
* re-BSE France

(41 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 16 Nov 1999 14:19:13 -0600
56. re-Swiss total cattle population
* re-Swiss total cattle population

(30 lines)
From: Terry S. Singeltary Sr.
Date: Sun, 14 Nov 1999 11:12:53 -0600
57. rehash a Q&A?
* rehash a Q&A?

(36 lines)
From: Tam Garland
Date: Mon, 29 Nov 1999 13:48:09 -0600
* Re: rehash a Q&A?

(56 lines)
From: Robert A. LaBudde
Date: Tue, 30 Nov 1999 02:21:42 -0500
58. Report of the Committee on Infectious Diseases of Cattle, Bison,
and Llama
* Report of the Committee on Infectious Diseases of Cattle,
Bison, and Llama

(74 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 10 Nov 1999 10:23:57 -0600
59. role of normal PrP
* role of normal PrP

(160 lines)
From: Helene Rudyk
Date: Sat, 13 Nov 1999 19:08:44 +0000
* Re: role of normal PrP

(233 lines)
From: Roland Heynkes
Date: Sun, 14 Nov 1999 04:06:39 +0100
* Re: role of normal PrP

(159 lines)
From: tom
Date: Sun, 14 Nov 1999 13:37:23 -0700
* Re: role of normal PrP

(97 lines)
From: tom
Date: Mon, 15 Nov 1999 16:56:51 -0700
60. Scientists identify cells needed for prion replication
* Scientists identify cells needed for prion replication

(45 lines)
From: Terry S. Singeltary Sr.
Date: Wed, 3 Nov 1999 09:25:41 -0600
* Scientists identify cells needed for prion replication

(228 lines)
From: tom
Date: Wed, 3 Nov 1999 10:47:53 -0700
* Re: Scientists identify cells needed for prion replication

(52 lines)
From: Roland Heynkes
Date: Wed, 3 Nov 1999 20:10:29 +0100
61. Second BSE lion details
* Second BSE lion details

(36 lines)
From: tom
Date: Fri, 19 Nov 1999 14:38:34 -0700
62. SOD normal prion function?
* SOD normal prion function?

(131 lines)
From: tom
Date: Mon, 8 Nov 1999 09:14:09 -0700
63. Sorry Siegfred......
* Sorry Siegfred......

(31 lines)
From: Terry S. Singeltary Sr.
Date: Sun, 14 Nov 1999 11:53:28 -0600
64. Southwood Working Party advice on baby food. >witness statement
184e - Meldrum issued 10/14/99
* Southwood Working Party advice on baby food. >witness
statement 184e - Meldrum issued 10/14/99

(898 lines)
From: Terry S. Singeltary Sr.
Date: Tue, 30 Nov 1999 12:32:34 -0600
65. SSC and "10 TSE experts"
* Re: SSC and "10 TSE experts"

(79 lines)
From: J Ralph Blanchfield
Date: Fri, 12 Nov 1999 11:34:41 +0000
* Re: SSC and "10 TSE experts"

(51 lines)
From: Roland Heynkes
Date: Fri, 12 Nov 1999 15:39:18 +0100
* Re: SSC and "10 TSE experts"

(80 lines)
From: Univ.-Prof.Dr.Herbert Budka
Date: Sat, 13 Nov 1999 15:55:05 +0100
* Re: SSC and "10 TSE experts"

(51 lines)
From: Roland Heynkes
Date: Sun, 14 Nov 1999 00:09:54 +0100
* Re: SSC and "10 TSE experts"

(86 lines)
From: Univ.-Prof.Dr.Herbert Budka
Date: Wed, 17 Nov 1999 12:35:45 +0100
* Re: SSC and "10 TSE experts"

(125 lines)
From: J Ralph Blanchfield
Date: Wed, 17 Nov 1999 14:07:44 +0000
66. Test for BSE-L - please ignore!
* Test for BSE-L - please ignore!

(28 lines)
From: Siegfried Schmitt
Date: Mon, 15 Nov 1999 20:12:47 +0100
67. the SSC decision in Brussels tonight
* the SSC decision in Brussels tonight

(73 lines)
From: Debora MacKenzie
Date: Sat, 30 Oct 1999 01:07:14 +0100
* Re: the SSC decision in Brussels tonight

(81 lines)
From: Roland Heynkes
Date: Wed, 10 Nov 1999 09:21:16 +0100
68. Uncertainty
* Re: Uncertainty

(81 lines)
From: Tim Sly
Date: Thu, 11 Nov 1999 22:55:11 -0500
69. US scientists develop a possible test for BSE
* US scientists develop a possible test for BSE

(28 lines)
From: Terry S. Singeltary Sr.
Date: Sun, 14 Nov 1999 11:09:58 -0600
70. USDA APHIS proposed scrapie rule to be published 11/30/99
* USDA APHIS proposed scrapie rule to be published 11/30/99

(37 lines)
From: tom
Date: Sun, 28 Nov 1999 20:56:58 -0700
71. verify your contact information
* verify your contact information

(38 lines)
From: tom
Date: Mon, 1 Nov 1999 08:09:22 -0700
72. Virgil M. Hulse Dies 11/13/99
* Re: Virgil M. Hulse Dies 11/13/99

(36 lines)
From: Dr. Virgil M. Hulse
Date: Sun, 14 Nov 1999 13:48:49 -0800
73. [Fwd: "CWD not a threat in Texas" HoustonChronicle.com]
* [Fwd: "CWD not a threat in Texas" HoustonChronicle.com]

(384 lines)
From: Terry S. Singeltary Sr.
Date: Thu, 11 Nov 1999 10:34:56 -0600
* Re: [Fwd: "CWD not a threat in Texas" HoustonChronicle.com]

(45 lines)
From: Roland Heynkes
Date: Fri, 12 Nov 1999 06:26:45 +0100
* Re: [Fwd: "CWD not a threat in Texas" HoustonChronicle.com]

(54 lines)
From: Terry S. Singeltary Sr.
Date: Fri, 12 Nov 1999 08:26:41 -0600
* Re: [Fwd: "CWD not a threat in Texas" HoustonChronicle.com]

(61 lines)
From: tom
Date: Fri, 12 Nov 1999 08:52:38 -0700

Terry S. Singeltary Sr. wrote:

> hello hatte,
>
> > FROM BRAIN OR SPINAL CORD MATERIAL IN BABY FOOD.
>
>
> indeed, they watered that down long ago.
> i will do a search of an old thread from long ago on BSE-L
> where i got chastised for slamming someone about baby
> foods that said that special precautions had been taken.
> i never said i was politically correct ;-)...terry
>
>
> Hatte Blejer wrote:
>
> > Terry,
> > Very disturbing article, particularly the following statements:
> >
> >
> > 1. "The cases we are seeing, peaking at age 27, must have been
> > infected in
> > about 1976 to 1980, well before the epidemic of BSE." THEY COULD HAVE
> > ARISEN, HE SAID, FROM BRAIN OR SPINAL CORD MATERIAL IN BABY FOOD.
> >
> > 2. Later on, during the 1980s and '90s, THE AVERAGE BRITON ATE 50 MEALS
> > CONTAINING BSE-INFECTED MATERIAL, and the incubation period can
> exceed 20
> > years.
> >
> > 3. "The way mathematicians look at the problem, is if they saw 10 cases
> > last week and the same number for the preceding six weeks, they assume
> > there
> > will be 10 next week.
> >
> > "But if you are a biologist, you look at incubation periods, life
> > expectancy
> > and other factors. . . . THE BIOLOGY OF THIS DISEASE SUGGESTS NUMBERS
> > WON'T
> > PEAK UNTIL (BETWEEN) 2010 AND 2020."
> >
> >
> >
> >
> >






Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: